← All Scilex Holding CO filings

Scilex Holding CO 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ
SCLX
Scilex Holding CO
10-K: Scilex Holding Company Details Securities and Financials
Scilex Holding Company's 10-K filing provides a comprehensive overview of its securities, financial performance, and strategic initiatives, including its foray into cryptocurrency.
NASDAQ
SCLX
Scilex Holding CO
10-K/A: Scilex Holding Files Amendment to 10-K, Addressing Executive Compensation and Governance
Scilex Holding Company files an amendment to its 2024 Annual Report on Form 10-K to include previously omitted information regarding executive compensation and corporate governance.
NASDAQ
SCLX
Scilex Holding CO
10-K: Scilex Holding Company's 10-K Filing Reveals Strategy for Non-Opioid Pain Management
Scilex Holding Company's 10-K filing highlights its focus on non-opioid pain management through commercialized products and pipeline development.
NASDAQ
SCLX
Scilex Holding CO
10-K: Scilex Holding Company Details Securities in 10-K Filing, Outlines Share Structure and Anti-Takeover Measures
Scilex Holding Company's recent 10-K filing provides a detailed overview of its securities, including common and preferred stock, warrants, and anti-takeover provisions.